Group structure
11 companies in 6 countries
Loading your page…
Loading your page…
11 companies in 6 countries
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine of every company in the group, current ones first.
1–25 of 118
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| DUACGel | Clindamycin, Benzoyl peroxide | Italy | Authorised | |
| DUAC5%; 1.2% · GEL | Benzoyl peroxide, Clindamycin | United States | Marketed | 2002 |
| Duac Acne Gel 10 mg/g + 50 mg/g, gelGel | Benzoyl peroxide, Clindamycin | Netherlands | Authorised | 2005 |
| SCABENE1% · Lotion | Lindane | United States | Not marketed | |
| SCABENE1% · Shampoo | Lindane | United States | Not marketed | |
| SORIATANE10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 17.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 22.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 25MG **Federal Regist · Capsule | Acitretin | United States | Not marketed | 1996 |
| TOCTINOCapsula molle | Alitretinoin | Italy | Authorised | |
| Toctino 10 mg, capsules, zachtCapsule, zacht | Alitretinoin | Netherlands | Authorised | 2009 |
| Toctino 30 mg, capsules, zachtCapsule, zacht | Alitretinoin | Netherlands | Authorised | 2009 |
| clindoxyl control | Brazil | Authorised | 2012 | |
| CLINDOXYL CONTROL | Brazil | Authorised | 2018 | |
| CLINDOXYL CONTROL | Brazil | Authorised | 2018 | |
| CLINDOXYL CONTROL | Brazil | Authorised | 2015 | |
| clindoxyl control | Brazil | Authorised | 2017 | |
| clindoxyl control | Brazil | Authorised | 2012 | |
| clindoxyl control | Brazil | Authorised | 2017 | |
| clindoxyl control | Brazil | Authorised | 2015 | |
| clindoxyl control | Brazil | Authorised | 2015 | |
| CLINDOXYL CONTROL | Brazil | Authorised | 2015 | |
| CLINDOXYL CONTROL 10% | Brazil | Authorised | 2015 | |
| ISOTREX GEL 0.05% | Isotretinoin | Saudi Arabia | Authorised | |
| ISOTREXIN GEL | Erythromycin, Isotretinoin | Saudi Arabia | Authorised | |
| PANOXYL 10 ACNE GEL | Benzoyl peroxide | Saudi Arabia | Authorised | |
| PANOXYL 5 ACNE GEL | Benzoyl peroxide | Saudi Arabia | Authorised | |
| PANOXYL 5 LOTION | Benzoyl peroxide | Saudi Arabia | Authorised |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Brazil | 68 | 13 | 55 | CompaniesAll medicines |
| Canada | 29 | 0 | 29 | CompaniesAll medicines |
| Saudi Arabia | 8 | 8 | 0 | CompaniesAll medicines |
| Spain | 4 | 0 | 4 | CompaniesAll medicines |
| United States | 4 | 4 | 0 | CompaniesAll medicines |
| Netherlands | 3 | 3 | 0 | CompaniesAll medicines |
| Italy | 2 | 2 | 0 | CompaniesAll medicines |
Also in the registers of France
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.
Fuente de la información: AEMPS (CIMA).
Licence: AEMPS open data reuse with attribution
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence: Public domain (U.S. Government work)
Source: BDPM (ANSM, HAS, UNCAM).
Licence: Licence Ouverte v1.0
Anvisa published factual open-data CSV https://dados.anvisa.gov.br/dados/CONSULTAS/PRODUTOS/TA_CONSULTA_MEDICAMENTOS.CSV, HTTP version Mon, 12 Oct 2026 11:45:25 GMT; acquired 12 October 2026; original source states and timestamps retained.
Licence: Brazil federal factual open data, consolidated Decreto 8777/2016 article 4; attribution and third-party exceptions
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
Licence: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
BDPM / ANSM, HAS and UNCAM; original URLs and each update date retained
Licence: BDPM exact Licence Ouverte v1.0 (October 2011)
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_H_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:40 GMT; acquired 2026-10-13T17:21:06.034935+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Ministero della Salute, Italy; https://www.dati.salute.gov.it/it/dataset/distributori-di-farmaci/; original CSV snapshot 15 October 2026, acquired 2026-10-15T13:26:43.659718+00:00; adapted factual fields under IODL2. Coordinates: © OpenStreetMap contributors, separate rights gate.
Licence: Italian Open Data Licence v2.0, exact dataset-catalog assignment; coordinate fields separately attributed to OpenStreetMap
Ministero della Salute, Distributori di farmaci, source file13Oct2026. https://www.dati.salute.gov.it/it/dataset/distributori-di-farmaci/; IODL2.0 https://www.dati.gov.it/content/italian-open-data-license-v20. Original URLs/locators and retrieval timestamps; selected/normalized by Prognia; no government endorsement.
Licence: Italian Open Data Licence
College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.
Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim
Saudi Food and Drug Authority (SFDA), foreign human medicine open-data listing, source scope 2023, retrieved 11 October 2026 UTC; exact original file and response modification date retained.
Licence: Exact SFDA open-data section explicitly offers freely usable named human medicine workbooks; factual-data scope only
Report an error or request removalCorrections from the company itself are welcome.
Well-known pharmaceutical groups, each with all its companies.